Comparative efficacy and safety of anti-cryptosporidial agents: an <i>in vitro</i> study on nitazoxanide, halofuginone lactate, KDU731, and paromomycin against <i>Cryptosporidium parvum</i>.

Front Microbiol · 2024 · PMC11486740 · PMID 39430109

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Due to the high variability, nitazoxanide displayed a modest decrease in the host cell viability (mean growth 74.7% ± 24.16 SD) but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.